Latest News

 Filter by Provider

CRISPR Therapeutics is a promising mid-cap biotech stock with an approved product in its portfolio.

Bund yields are falling by more than equities would justify. From the demand side, we may have more investors seeking safe havens from market turmoil, whilst from a supply perspective, we see very little net issuance in October versus other months.

A stock split makes a stock more accessible to a wider range of investors.

The company said its cancer drug SLS009 showed strong preclinical results in T-cell prolymphocytic leukemia, improving survival and reducing tumor burden both alone and in combination with venetoclax.

Dave Ramsey warns family of 11 that $50,000 debt is a result of poor financial planning, not children's activities.

Management also said OpenAI was not Broadcom's mysterious $10 billion customer.

Jeff Bezos believes humans could live in space within decades. He also supports using robots for space work.

Travere Therapeutics (TVTX) shows strong growth momentum with accelerating earnings and revenue. Its high technical rating and clear setup pattern offer a compelling investment case.

Microsoft's Copilot is already helping generate billions in revenue, while Apple is in the midst of enhancing its iPhones with new AI features.

You don't want to get out of the stock market altogether, but now would be a good time to start playing a little defense.

One of Wall Street's most-successful asset managers sent a skyrocketing artificial intelligence (AI) stock packing in favor of a healthcare turnaround story.

Using indicators like industrial production, manufacturing output, and capacity utilization, the article examines real-time business cycle signals—especially as some data series become unavailable during the government shutdown.

Fear & Greed index increased, but remained in Fear zone. Nasdaq rose with optimism over strong earnings & Fed rate cuts.

The flash crash wasn't kind to many coins, but this one held up fairly well.

Bank of New York Mellon, Charles Schwab, KeyCorp., Commercial Metals, M&T Bank, Marsh McLennan, Travelers, U.S. Bancorp, CSX, and Interactive Brokers are due to release their quarterly results.

Find out if the deal Omeros announced is enough of a reason to buy this stock.

American Resources shares bounced in after-hours trading after the company announced a $40 million private placement.

Investors continue to overlook the massive progress this company has made, but October brings more proof.

A record shutdown? Moody's Chief Economist warns of a 5-6 week stalemate and economic fallout that could "get ugly fast." Here's the outlook.

This rapidly rising cost is bad news for seniors relying on Social Security in retirement.

Gold and silver are being swept up in a sweeping shift — as global confidence in fiat currencies wanes, precious metals become the anchor amid mounting volatility and structural change.

Can Target overcome its issues around sales and profit?

Berkshire Hathaway is about to see the biggest change in its business in decades, but you shouldn't let that stop you from buying it.

Yes, these are three elite businesses with powerful fundamentals. But tread carefully, as their valuations look stretched.

U.S. stock futures slightly up on Thursday, with focus on earnings reports from Charles Schwab, J.B. Hunt, Travelers, TSMC, and US Bancorp.

There's a new key date to keep in mind.

Norway proposes to revise EV incentives, which could affect the company's sales in the country as well as Europe.

After 17 years of operation, NuScale Power has an exciting future ahead.

Sen. Warren accuses White House of dismantling consumer watchdog, as budget director Vought says CFPB could close within months. $21B returned to Americans thanks to CFPB.

This under-the-radar business development company might be the safest double-digit-yielding stock on the planet.

Ken Griffin is one of the most successful hedge fund managers in history, and he bought a small position in Palantir in the second quarter.

The digital retail, cloud, and artificial intelligence (AI) specialist has a lot going on. Is it time to buy?

NuScale Power Corp (SMR) rallied more than 20% yesterday after the US Army launched a new initiative aimed at deploying micro nuclear reactors.

The Trump administration is reportedly gearing up to broaden the scope of Internal Revenue Service (IRS) investigations.

SCOTUS conservative justices may weaken Section 2 of Voting Rights Act, impacting minority representation in districts. Liberal justices push back while lawmakers urge Congress to protect rights.

Microvast jumped in after-hours trading following China's new export restrictions on rare-earth materials.

Silver’s squeeze and gold’s surge are strong signals, but this article warns not to treat just the symptoms. It argues that the real illness (inflation, monetary policy) demands a deeper focus to understand these precious metal moves

Florida Governor Ron DeSantis (R) weighed in on the recent surge in precious metals, linking it to a broader crisis of confidence in the U.S. monetary system.